| #103 |
Lisa Beebe |
Bristol-Myers Squibb |
1 |
| #103 |
Aleksandr E. Petrov |
IBM |
1 |
| #103 |
Shengjin JIN |
Immunogen |
1 |
| #103 |
James V. Luciani |
Nortel Networks Limited |
1 |
| #103 |
Stephen E. Korbly |
Passport Systems |
1 |
| #103 |
Kicherl Ho |
480 Biomedical |
1 |
| #103 |
Deborah Ellen Fitzgerald |
Avaya |
1 |
| #103 |
Joe Jones |
Apple |
1 |
| #103 |
Steven Hart |
Rai Strategic Holdings |
1 |
| #103 |
Michael D. McCreary |
E Ink Holdings |
1 |
| #103 |
Sungyung Lim |
Draper Laboratory |
1 |
| #103 |
Krishnamoorthy Arvind |
Adva Optical Networking Se |
1 |
| #103 |
John Healy |
ExxonMobil |
1 |
| #103 |
Yun Jin Rho |
Pearson Education |
1 |
| #103 |
David Klatte |
The Travelers Indemnity |
1 |
| #103 |
Mark J. Fiandaca |
Boston Probes |
1 |
| #103 |
Donna-Ruth W. Yost |
MIT |
1 |
| #103 |
Changqing Wang |
Verizon |
1 |
| #103 |
Mehmet Aydinlik |
Acacia Communications |
1 |
| #103 |
Arunabha Nag |
Dassault Systemes Solidworks |
1 |
| #103 |
Paul Haverstock |
IBM |
1 |
| #103 |
Zhigang Chen |
Enanta Pharmaceuticals |
1 |
| #103 |
Donovan O'Hara |
Cisco |
1 |
| #103 |
Antonio Gualberto |
Kura Oncology |
1 |
| #103 |
Sreedhar Sistu |
— |
1 |
| #103 |
Angela Widom |
Pfizer |
1 |
| #103 |
Frank Peter Stegmeier |
Novartis Ag |
1 |
| #103 |
Nagendra Anantharamaiah |
Hollingsworth & Vose |
1 |
| #103 |
John W. Blankenship |
Aptevo Research And Development |
1 |
| #103 |
Terence Lobo |
Akamai Technologies |
1 |
| #103 |
Roderick R. Kunz |
MIT |
1 |
| #103 |
Bruce A. Rasmussen |
— |
1 |
| #103 |
Ben Hertz |
Allen Medical Systems |
1 |
| #103 |
George Zavaliagkos |
Microsoft |
1 |
| #103 |
Robert Sprague |
Materion |
1 |
| #103 |
Alan J. Bitonti |
Syntonix Pharmaceuticals |
1 |
| #103 |
Malini Viswanathan |
Dyax |
1 |
| #103 |
Yongyao Cai |
Rockwell Automation |
1 |
| #103 |
Minghua Wang |
Forma Therapeutics |
1 |
| #103 |
Ganesh Prasanna |
Novartis Ag |
1 |
| #103 |
Richard Wallace |
Evergreen Solar |
1 |